Fractyl Health, Inc. Common Stock (GUTS)
GUTS Stock Price Chart
Explore Fractyl Health, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze GUTS price movements and trends.
GUTS Company Profile
Discover essential business fundamentals and corporate details for Fractyl Health, Inc. Common Stock (GUTS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
2 Feb 2024
Employees
107.00
Website
https://fractyl.comCEO
Harith Rajagopalan
Description
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.
GUTS Financial Timeline
Browse a chronological timeline of Fractyl Health, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.34.
Earnings released on 12 Aug 2025
EPS came in at -$0.53 falling short of the estimated -$0.37 by -43.24%.
Earnings released on 13 May 2025
EPS came in at -$0.49 matching the estimated -$0.49.
Earnings released on 3 Mar 2025
EPS came in at -$0.52 falling short of the estimated -$0.44 by -18.18%, while revenue for the quarter reached $3.00K , missing expectations by -70.00%.
Earnings released on 12 Nov 2024
EPS came in at -$0.48 surpassing the estimated -$0.50 by +4.00%, while revenue for the quarter reached $14.00K .
Earnings released on 14 Aug 2024
EPS came in at -$0.36 surpassing the estimated -$0.46 by +21.74%, while revenue for the quarter reached $43.00K .
Earnings released on 13 May 2024
EPS came in at -$0.75 falling short of the estimated -$0.30 by -150.00%, while revenue for the quarter reached $33.00K .
Earnings released on 1 Apr 2024
EPS came in at -$8.02 falling short of the estimated -$0.65 by -1.13K%, while revenue for the quarter reached $7.00K .
Earnings released on 30 Sept 2023
EPS came in at -$0.33 , while revenue for the quarter reached $36.00K .
Earnings released on 30 Jun 2023
EPS came in at -$0.63 , while revenue for the quarter reached $72.00K .
Earnings released on 31 Mar 2023
EPS came in at -$0.25 , while revenue for the quarter reached $5.00K .
Earnings released on 30 Dec 2022
EPS came in at -$0.23 .
Earnings released on 30 Sept 2022
EPS came in at -$7.54 .
Earnings released on 30 Dec 2021
EPS came in at -$0.26 .
Earnings released on 29 Sept 2021
EPS came in at -$0.19 .
Earnings released on 30 Dec 2020
EPS came in at -$0.17 .
Earnings released on 29 Sept 2020
EPS came in at -$0.16 .
GUTS Stock Performance
Access detailed GUTS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.